|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
3,103 |
$95,665.72 |
2.94% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
3,999 |
$94,801.50 |
2.91% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
1,207 |
$84,188.25 |
2.58% |
| Insulet Corporation |
PODD |
45784P101 |
356 |
$83,257.72 |
2.56% |
| ResMed Inc. |
RMD |
761152107 |
335 |
$83,391.55 |
2.56% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
5,216 |
$81,875.49 |
2.51% |
| Hoya Corporation |
7741.JP |
J22848105 |
594 |
$80,432.41 |
2.47% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
162 |
$79,357.32 |
2.44% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,440 |
$79,526.29 |
2.44% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
221 |
$79,193.73 |
2.43% |
| Boston Scientific Corporation |
BSX |
101137107 |
916 |
$76,311.96 |
2.34% |
| Alcon Inc. |
ALC.SW |
H01301128 |
766 |
$75,195.96 |
2.31% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,834 |
$75,350.17 |
2.31% |
| Steris Plc |
STE |
G8473T100 |
306 |
$74,917.98 |
2.30% |
| Revvity, Inc. |
RVTY |
714046109 |
602 |
$73,462.06 |
2.26% |
| The Cooper Companies, Inc. |
COO |
216648501 |
667 |
$73,723.51 |
2.26% |
| Teleflex Incorporated |
TFX |
879369106 |
291 |
$71,600.55 |
2.20% |
| Danaher Corporation |
DHR |
235851102 |
260 |
$71,305.00 |
2.19% |
| Medtronic Plc |
MDT |
G5960L103 |
778 |
$70,020.00 |
2.15% |
| BioMerieux |
BIM.FP |
F1149Y232 |
561 |
$68,424.49 |
2.10% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
208 |
$67,853.76 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
49 |
$67,769.94 |
2.08% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
482 |
$67,388.97 |
2.07% |
| Stryker Corporation |
SYK |
863667101 |
182 |
$67,385.50 |
2.07% |
| Terumo Corporation |
4543.JP |
J83173104 |
3,660 |
$67,204.42 |
2.06% |
| Abbott Laboratories |
ABT |
002824100 |
571 |
$66,464.40 |
2.04% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
13,878 |
$66,366.80 |
2.04% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
108 |
$66,006.36 |
2.03% |
| Hologic, Inc. |
HOLX |
436440101 |
806 |
$65,406.90 |
2.01% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
723 |
$62,835.93 |
1.93% |
| Waters Corporation |
WAT |
941848103 |
193 |
$62,890.98 |
1.93% |
| Becton, Dickinson and Company |
BDX |
075887109 |
265 |
$62,057.70 |
1.91% |
| Baxter International Inc. |
BAX |
071813109 |
1,546 |
$61,407.12 |
1.89% |
| Agilent Technologies, Inc. |
A |
00846U101 |
443 |
$60,828.33 |
1.87% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,098 |
$60,562.78 |
1.86% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
410 |
$59,638.14 |
1.83% |
| Cochlear Limited |
COH.AU |
Q25953102 |
301 |
$58,680.56 |
1.80% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,372 |
$58,006.58 |
1.78% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,867 |
$57,208.14 |
1.76% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
855 |
$56,036.70 |
1.72% |
| Penumbra, Inc. |
PEN |
70975L107 |
287 |
$53,651.78 |
1.65% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
501 |
$53,236.26 |
1.63% |
| Masimo Corporation |
MASI |
574795100 |
452 |
$50,985.60 |
1.57% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
164 |
$49,309.88 |
1.51% |
| Align Technology, Inc. |
ALGN |
016255101 |
198 |
$48,258.54 |
1.48% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
691 |
$47,347.32 |
1.45% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
229 |
$46,881.20 |
1.44% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
573 |
$35,451.86 |
1.09% |
| DexCom, Inc. |
DXCM |
252131107 |
458 |
$31,835.58 |
0.98% |
| US Dollar |
$USD |
|
5,842 |
$5,842.00 |
0.18% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.09 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|